Not yet recruiting NCT07255443
Intestinal Colonization With Carbapenem Resistant Enterobacteriaceae Among ICU Patients at Assiut University Hospital
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Observational study.
- Who it may be relevant to
- Registry conditions: Rate of Carbapenemase Intestinal Carrier Inside ICU. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
significant benefits by providing data to improve infection control, guide early detection, and reduce CRE transmission in ICUs.
Interventions
- Other Observational study
Observational study
Primary outcome measures
- rate of intestinal colonization with CRE [Time frame: One year]
Eligibility criteria
Inclusion criteria
- Adults (≥18 years)\_
- Expected ICU stay ≥48 hours -
Exclusion criteria
- .ICU stay <48 hours
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07255443 · Assiut_icu_catbapenem_2025